Elesclomol

N/A

Report date: 2024/05/07 20:00:09
NME

Base Information

Drug NameElesclomol
Drug Alias Nameelesclomolum依来罗莫elesclomol伊利司莫伊来司莫 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock 70 kDa protein 1 inducers
TargetsHeat shock 70 kDa protein 1
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesRomania +[8] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMadrigal Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEngrail Therapeutics IncMadrigal Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursProstatic NeoplasmsCarcinoma, Non-Small-Cell Lung +[7] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG